Hormone Replacement Therapy Market, By Therapy Type (Human Growth Hormone (HGH) Replacement Therapy, Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy), By Application (Growth Hormone Deficiency, Menopause, Hypothyroidism, Male Hypogonadism, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa ) - Trends, Analysis and Forecast till 2030

Hormone replacement therapy is the medications, which is used for treatment of improper synthesize of hormone required by the body. Hormone replacement therapies are widely used in the treatment of growth hormone deficiency, menopause, hypothyroidism, male hypogonadism.  Hormone replacement therapies are therapeutics used in treatment of various hormone related disorders. Hormone replacement therapy are widely used for treatment of improper synthesize of hormone required by the body for example these therapies are widely used in treatment of growth hormone deficiency, menopause, hypothyroidism, and male hypogonadism. Most common types of hormone replacement therapies used in the market are human growth hormone (HGH) replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and estrogen replacement therapy. Hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

High prevalence of hormone related disorder

The robust pipeline of novel hormone replacement therapies which are under pipeline and are expected to get approval in near future is expected to be prominent factor driving market growth over the forecast period. For instance, in March 2018, TherapeuticsMD, Inc. announced that the U.S. Food and Drug Administration (FDA) have accepted its New Drug Application (NDA) for TX-001HR, an oral hormone combination therapy, for the treatment of moderate-to-severe vasomotor symptoms due to menopause. Furthermore, high prevalence of hormone related disorder is also expected to be a major factor driving growth of the market by rising demand for hormone replacement products in the market. For instance, as per estimated of American Thyroid Association (ATA), More than 12 percent of the U.S. population will develop a thyroid condition during their lifetime and around 20Mn Americans have some form of thyroid disease.

Hormone replacement therapy market has been segmented on the basis of therapy type, application, route of administration, distribution channel and region.

On the basis of therapy type, the global hormone replacement therapy market has been segmented in human growth hormone (HGH) replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and estrogen replacement therapy. On the basis of application, the global hormone replacement therapy market has been segmented in growth hormone deficiency, menopause, hypothyroidism, male hypogonadism, and others. On the basis of route of administration, the global hormone replacement therapy market has been segmented in oral, parenteral, and others. On the basis of distribution channel, the global hormone replacement therapy market has been segmented in hospital, retail pharmacies, and online pharmacies.

Regional Insights:

For detailed understanding of market dynamics, the global Insulin Biosimilar market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, North America market dominated the global Insulin Biosimilar market due to high prevalence of hormone disorder patients in this region which turns into high demand for these therapies. Further, Europe hormone replacement therapy market is expected to account for second largest revenue share in the global market due to early development in the field of healthcare in the countries of the region. Asia Pacific market is expected to witness fastest growth in terms of revenue over the forecast period.

Report Scope:

Hormone Replacement Therapy Market, By Therapy Type:

• • • Human Growth Hormone (HGH) Replacement Therapy
    • Testosterone Replacement Therapy
    • Thyroid Replacement Therapy
    • Estrogen Replacement Therapy

Hormone Replacement Therapy Market, By Application:

• • • Growth Hormone Deficiency
    • Menopause
    • Hypothyroidism
    • Male Hypogonadism
    • Others

Hormone Replacement Therapy Market, By Route of Administration

• • • Oral
    • Parental
    • Others

Hormone Replacement Therapy Market, By Distribution Channel:

• • • Retail Pharmacy
    • Online Pharmacy
    • Hospitals Pharmacy

Hormone Replacement Therapy Market, By Geography:

• North America
  • North America Hormone Replacement Therapy Market, By Therapy Type
  • North America Hormone Replacement Therapy Market, By Application
  • North America Hormone Replacement Therapy Market, By Route of Administration
  • North America Hormone Replacement Therapy Market, By Distribution Channel
  • North America Hormone Replacement Therapy Market, By Country
    • • • U.S.
        • Canada
    • Europe
  • Europe Hormone Replacement Therapy Market, By Therapy Type
  • Europe Hormone Replacement Therapy Market, By Application
  • Europe Hormone Replacement Therapy Market, By Route of Administration
  • Europe Hormone Replacement Therapy Market, By Distribution Channel
  • Europe Hormone Replacement Therapy Market, By Country
    • • • Germany
        •  UK
        • France
        • Russia
        • Italy
        • Switzerland
        • Sweden
        • Rest of Europe
    • Asia-Pacific
  • Asia-Pacific Hormone Replacement Therapy Market, By Therapy Type
  • Asia Pacific Hormone Replacement Therapy Market, By Application
  • Asia Pacific Hormone Replacement Therapy Market, By Route of Administration
  • Asia-Pacific Hormone Replacement Therapy Market, By Distribution Channel
  • Asia-PacificHormone Replacement Therapy Market, By Country
    • • • China
        • India
        • Australia & New Zealand
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
  • Latin AmericaHormone Replacement Therapy Market, By Therapy Type
  • Latin America Hormone Replacement Therapy Market, By Application
  • Latin America Hormone Replacement Therapy Market, By Route of Administration
  • Latin America Hormone Replacement Therapy Market, By Distribution Channel
  • Latin AmericaHormone Replacement Therapy Market, By Country
    • • • Brazil
        •  Mexico
        • Argentina and Chile
        • Rest of Latin America
    • Middle East
  • Middle East Hormone Replacement Therapy Market, By Therapy Type
  • Middle East Hormone Replacement Therapy Market, By Application
  • Middle East Hormone Replacement Therapy Market, By Route of Administration
  • Middle East Hormone Replacement Therapy Market, By Distribution Channel
  • Middle East Hormone Replacement Therapy Market, By Country
    • • • GCC
        •  Israel
        •  Saudi Arabia
        • UAE
        •  Rest of Middle East
    • Africa
  • Africa Hormone Replacement Therapy Market, By Therapy Type
  • Africa Hormone Replacement Therapy Market, By Application
  • Africa Hormone Replacement Therapy Market, By Route of Administration
  • Africa Hormone Replacement Therapy Market, By Distribution Channel
  • Africa Hormone Replacement Therapy Market, By Country
    •  North Africa
    • South Africa
    • Central Africa

Key players operating in the global Hormone replacement therapy market includes, Merck KgaA, Abbott Laboratories, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Bayer AG, QuatRx Pharmaceuticals, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Novo Nordisk A/S.

Market Taxonomy

This report segments the global hormone replacement therapy market on the basis of therapy type, application, route of administration, distribution channel, and region. On the basis of therapy type, the global hormone replacement therapy market has been segmented in human growth hormone (HGH) replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and estrogen replacement therapy. On the basis of application, the global hormone replacement therapy market has been segmented in growth hormone deficiency, menopause, hypothyroidism, male hypogonadism, and others. On the basis of route of administration, the global hormone replacement therapy market has been segmented in oral, parenteral, and others. On the basis of distribution channel, the global hormone replacement therapy market has been segmented in retail pharmacies, online pharmacies and hospitals pharmacy. Further, on the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions. For detailed understanding of market dynamics, the global hormone replacement therapy market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

Prophecy Market Insights provides detailed analysis on hormone replacement therapy in our report- Global hormone replacement therapy by therapy type, by application, by route of administration, by distribution channel, and by region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2018 – 2028, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global hormone replacement therapy based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices includes in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the hormone replacement therapy.

• Merck KgaA
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Abbott Laboratories
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Eli Lilly and Company
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Novartis International AG
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Pfizer Inc.
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Bayer AG
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• QuatRx Pharmaceuticals
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Mylan N.V.
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• TevaPharmaceutical Industries Ltd.
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Amgen, Inc.
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview
• Novo Nordisk A/S
  • • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies Overview